SCHEDULE: Long Focus Capital Management Discloses Bicycle Therapeutics Stake

Long Focus Capital Management and John Helmers have reported a 6.6% beneficial ownership stake in Bicycle Therapeutics PLC's American Depositary Shares.

Summary

• Long Focus Capital Management, LLC and John Helmers have filed a Schedule 13G, indicating beneficial ownership of 3,310,687 American Depositary Shares (ADS) of Bicycle Therapeutics PLC.
• This represents approximately 6.6% of the class of securities.
• The filing date is March 31, 2026, with the report signed on May 15, 2026.
• Long Focus Capital Management, LLC is a Delaware limited liability company, and John Helmers is a U.S. citizen.
• The reporting persons state that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing neutrally as it is a routine ownership disclosure and does not provide performance or strategic information about the company.

Positives

• Significant stake reported by an investment management firm, potentially indicating confidence in the company's prospects.
• The filing confirms that the shares are held in the ordinary course of business, suggesting a passive investment approach rather than an attempt to gain control.

Negatives

• The filing does not contain any financial performance data or operational updates, making it difficult to assess the company's current health.
• The information is limited to ownership disclosure, offering no insight into the company's strategic direction or challenges.

Risks

• The filing does not explicitly mention any risks. However, any investment in publicly traded securities carries inherent market risks.
• As a Schedule 13G filing, it indicates a passive investment, but a change in strategy by the reporting persons could impact the stock price.

Future Outlook

The filing does not contain any forward-looking statements or guidance from the company. It solely pertains to ownership disclosure.

Management Comments

• "Securities reported on this statement on Schedule 13G as being beneficially owned by Long Focus Capital Management, LLC were purchased on behalf of its clients and no one client owns more than 5 percent of a class of such securities."
• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes in publicly traded companies. This filing indicates Long Focus Capital Management's interest in Bicycle Therapeutics, a biopharmaceutical company, which is typical for investment firms specializing in the healthcare or biotechnology sectors.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by an investment firm may be viewed positively, suggesting external confidence, but the passive nature of the filing limits immediate impact.
• Management: The filing confirms the investment is not intended to influence control, which may provide some stability regarding activist investor concerns.
• Creditors: No direct impact is indicated as the filing is purely an ownership disclosure.

Next Steps

• Monitor future filings from Long Focus Capital Management and John Helmers for any changes in their ownership stake.
• Observe Bicycle Therapeutics PLC's operational and financial performance for insights into the company's value.

Key Dates

Keywords

Bicycle Therapeutics, Schedule 13G, Long Focus Capital Management, John Helmers, Beneficial Ownership, American Depositary Shares, Investment Management, Securities Filing